|Bid||2.0400 x 900|
|Ask||2.0500 x 3100|
|Day's Range||2.0100 - 2.1200|
|52 Week Range||1.7300 - 4.5400|
|Beta (3Y Monthly)||2.10|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and solid R&D focus. However, operating losses remain a woe.
OPKO Health (OPK) delivered earnings and revenue surprises of 9.09% and 1.12%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Opko Health (NYSE: OPK ) unveils its next round of earnings this Wednesday, August 7. Here is Benzinga's everything-that-matters guide for the earnings announcement. Earnings and Revenue Analysts are predicting ...
OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Details the CEO buys this past week for the following companies: G-III Apparel Group, W&T; Offshore, HealthEquity, DXC Technology and OPKO Health Continue reading...
The largest Insider Buys this week were for Thor Industries Inc. (THO), Sinclair Broadcast Group Inc. (SBGI), OPKO Health Inc. (OPK), and Perspecta Inc. (PRSP). Continue reading...
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]
He was among a group of individuals and companies, including billionaire Phillip Frost, who allegedly participated in a penny stock "pump and dump" scheme.
OPKO Health Inc NASDAQ/NGS:OPKView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NegativeShort interest is moderately high for OPK with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding OPK are favorable, with net inflows of $2.95 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Biotech stocks came under pressure this week ahead of the ASCO 2019 presentations. Headlines on legal woes related to the opioid crisis and drug price manipulation led to weakness in some stocks. The unfolding ...